Trials that use: P-values
New to this method? Read the tutorial →
10,701 results
- HIDEIndependent statistical analysis of Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HIDO-LIDOIndependent statistical analysis of High Dose IV Lidocaine vs Hydromorphone for Abdominal Pain in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Hidradenitis Suppurativa Phase 2b Study of Izokibep: Complete Statistical AnalysisIndependent statistical analysis of Hidradenitis Suppurativa Phase 2b Study of Izokibep: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05355805).
- Hidradenitis Suppurativa Wound Care: Complete Statistical AnalysisIndependent statistical analysis of Hidradenitis Suppurativa Wound Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04354012).
- High Deductible Health Plans and Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of High Deductible Health Plans and Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02560701).
- High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin’s Lymphoma or Central Nervous System (CNS) Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population: Complete Statistical AnalysisIndependent statistical analysis of High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer: Complete Statistical AnalysisIndependent statistical analysis of High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions: Complete Statistical AnalysisIndependent statistical analysis of High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- High Dose or High Dose Frequency Study of Alglucosidase Alfa: Complete Statistical AnalysisIndependent statistical analysis of High Dose or High Dose Frequency Study of Alglucosidase Alfa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00483379).
- High Dose Oxytocin Nasal Spray for Treatment of Tinnitus: Complete Statistical AnalysisIndependent statistical analysis of High Dose Oxytocin Nasal Spray for Treatment of Tinnitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210310).
- High Frequency Impulse Therapy for Neuropathic Pain in NMOSD: Complete Statistical AnalysisIndependent statistical analysis of High Frequency Impulse Therapy for Neuropathic Pain in NMOSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04614454).
- High MAP in Septic Shock With Hypertension: Complete Statistical AnalysisIndependent statistical analysis of High MAP in Septic Shock With Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01443494).
- High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders: Complete Statistical AnalysisIndependent statistical analysis of High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: Complete Statistical AnalysisIndependent statistical analysis of High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- High-dose Bevacizumab in Advanced Renal Carcinoma Patients: Complete Statistical AnalysisIndependent statistical analysis of High-dose Bevacizumab in Advanced Renal Carcinoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00455975).
- High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML: Complete Statistical AnalysisIndependent statistical analysis of High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00774046).
- High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB): Complete Statistical AnalysisIndependent statistical analysis of High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Complete Statistical AnalysisIndependent statistical analysis of High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): primary endpoint results, effect estimate with confidence interval, sample-size…
- High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00349778).
- High-dose vs. Standard-dose Cephalexin for Cellulitis: Complete Statistical AnalysisIndependent statistical analysis of High-dose vs. Standard-dose Cephalexin for Cellulitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04471246).
- High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03388619).
- HIIT-SCIIndependent statistical analysis of Feasibility of HIIT in Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03152110).
- HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HIMALAYAComplete statistical analysis of the phase 3 HIMALAYA trial of durvalumab and tremelimumab in advanced hepatocellular carcinoma, including trial design, overall survival, non-inferiority methodology, Cox regression, log-rank testing, and interpretation.
- HIP: Hip Imaging Protocol: Complete Statistical AnalysisIndependent statistical analysis of HIP: Hip Imaging Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04126161).
- HIPCVAX-010SIndependent statistical analysis of Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HIPPERIndependent statistical analysis of Feasibility of the Hip Instructional Prehabilitation Program for Enhanced Recovery (HIPPER): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HIPPOIndependent statistical analysis of Helping Improve Pediatric Patient Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03471221).
- Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HiRTIndependent statistical analysis of Hyperglycemia in Renal Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01643382).
- Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast: Complete Statistical AnalysisIndependent statistical analysis of Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Histological Comparison of Ridge Preservation Using Mineralized FDBA Alone Versus a Combined Mineralized-Demineralized Freeze Dried Bone Allograft: Complete Statistical AnalysisIndependent statistical analysis of Histological Comparison of Ridge Preservation Using Mineralized FDBA Alone Versus a Combined Mineralized-Demineralized Freeze Dried Bone Allograft: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Histopathological Evaluation of the Periodontal Ligament Subjected to Laser Ablation.: Complete Statistical AnalysisIndependent statistical analysis of Histopathological Evaluation of the Periodontal Ligament Subjected to Laser Ablation.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06173648).
- Historical Case Record Survey of Visual Acuity Data From Patients With Leber’s Hereditary Optic Neuropathy (LHON): Complete Statistical AnalysisIndependent statistical analysis of Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- HITCHIndependent statistical analysis of Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HIV and Kidney Function Study: Complete Statistical AnalysisIndependent statistical analysis of HIV and Kidney Function Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00905151).
- HIV Self Testing of Male Partners of Women in PMTCT: Complete Statistical AnalysisIndependent statistical analysis of HIV Self Testing of Male Partners of Women in PMTCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03484533).
- HIV Vaccine Trial in Thai Adults: Complete Statistical AnalysisIndependent statistical analysis of HIV Vaccine Trial in Thai Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00223080).
- HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02370160).
- HMO Research Network CERT: Acute Myocardial Infarction: Complete Statistical AnalysisIndependent statistical analysis of HMO Research Network CERT: Acute Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00211172).
- HNC-RCIndependent statistical analysis of Development and Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HNSCCIndependent statistical analysis of Single-arm Study With Bimiralisib in Patients With HNSCC Harboring NOTCH1 Loss of Function Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE): Complete Statistical AnalysisIndependent statistical analysis of Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02798471).
- HOMEIndependent statistical analysis of Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Home Based Daratumumab Administration for Patients With Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Home Based Daratumumab Administration for Patients With Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05511428).
- Home Pulmonary Rehabilitation for COPD: Complete Statistical AnalysisIndependent statistical analysis of Home Pulmonary Rehabilitation for COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03480386).
- Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women: Complete Statistical AnalysisIndependent statistical analysis of Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04005391).
- Home-based Digital Exercise Training Program to Improve Physical Function of Older Sepsis Survivors – HEAL Sepsis Trial: Complete Statistical AnalysisIndependent statistical analysis of Home-based Digital Exercise Training Program to Improve Physical Function of Older Sepsis Survivors - HEAL Sepsis Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…